Skip to main content
. 2022 Nov 9;45(4):533–538. doi: 10.1097/FTD.0000000000001054

TABLE 3.

Composite Outcome and Its Components

Occurrence n (%) Target Trough Level 1-2 mg/L N = 36 Occurrence n (%) Target Trough Level 2–4 mg/L N = 10 P *
Composite endpoint 23 (63.9) 6 (60.0) 1.0
>1 log10 rise in viral load 22 (61.1) 6 (60.0) 1.0
Initiation of foscarnet 8 (22.2) 0 (0) 0.17
Resistance analysis 10 (27.8) 4 (40) 0.46
*

t test